| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |